New award for sildenafil citrate tablets with exelan. Ordering period is OCT 27, 2022 to OCT 26, 2023 with four one-year options
Ended Indefinite Delivery Contract Awarded Last action
- Contract number
- 36E79722D0026
- Awardee
-
Exelan Pharmaceuticals Inc. UEI FYZXNHSQTMG8
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- 6505--Sildenafil Citrate Tablets Pre-Solicitation · 36E79722R0019 · Posted Mar 24, 2022
- Last date to order 100% complete
- IDV ceiling
- $10,379,933.80
- Award type
- Single award
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 8 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Department of Veterans Affairs National Acquisition Center awarded a single-award indefinite-delivery contract to Exelan Pharmaceuticals Inc. for sildenafil citrate tablets, with a ceiling of $10,379,933.80, effective October 27, 2022. The ordering period runs from October 27, 2022 through October 26, 2023, with four one-year options exercisable through October 26, 2026. No set-aside applies; the contract is fully open competitive.
Performance occurs at Exelan's primary manufacturing and distribution facility in Boca Raton, Florida, with secondary locations in Cary, North Carolina; Summit, New Jersey; Ottawa, Ontario, Canada; and other designated federal delivery locations as specified by the Department of Veterans Affairs. The originating solicitation, posted March 24, 2022, sought supply of sildenafil citrate tablets as a pharmaceutical preparation. NAICS 325412 (Pharmaceutical Preparation Manufacturing) and PSC 6505 (Drugs and Biologicals) apply. A modification issued in April 2026 incorporated Executive Order 14398 Section 5 compliance language (FAR 52.222-90) addressing discrimination in federal contracting.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Add Subcontract Plan | $0 | |
| Exercise an Option | $0 | |
| Exercise an Option | $0 | |
| Exercise an Option | $0 | |
| Other Administrative Action | $0 | |
| Add Subcontract Plan | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $0 | |
| Other Administrative Action | $0 | |
| Add Subcontract Plan | $0 | |
| Original award | $0 |
Show all 13
Quick answers
Who was awarded contract 36E79722D0026?
36E79722D0026 was awarded to Exelan Pharmaceuticals Inc. by National Acquisition Center (Headquarters) on October 27, 2022.
How much is contract 36E79722D0026 worth?
36E79722D0026's own ceiling is $10,379,934.
Who can order from contract 36E79722D0026?
36E79722D0026 is a single award indefinite delivery contract.
Was contract 36E79722D0026 competed?
The extent of competition for 36E79722D0026 was full and open competition. The government received 8 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV